As of January 2025, Samjin Pharmaceuticals has a market cap of $166.26M. This makes Samjin Pharmaceuticals the world's 17316th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $181.33M | -4.17% |
2023 | $189.21M | -15.79% |
2022 | $224.69M | -2.47% |
2021 | $230.38M | -3.49% |
2020 | $238.70M | 9.22% |
2019 | $218.56M | -37.86% |
2018 | $351.70M | 11.99% |
2017 | $314.04M | 3.17% |
2016 | $304.40M | 49.46% |
2015 | $203.66M | 8.64% |
2014 | $187.46M | 48.10% |
2013 | $126.58M | 35.68% |
2012 | $93.29M | 33.96% |
2011 | $69.64M | -30.26% |
2010 | $99.86M | -5.58% |
2009 | $105.76M | 44.65% |
2008 | $73.11M | -24.57% |
2007 | $96.93M | 25.77% |
2006 | $77.07M | -5.93% |
2005 | $81.92M | - |